張 明,魏劍波
(四川省攀枝花市中心醫(yī)院,攀枝花 617067)
甲狀腺、垂體激素在中重型顱腦損傷患者中的檢測意義
張 明,魏劍波
(四川省攀枝花市中心醫(yī)院,攀枝花 617067)
目的:探析甲狀腺激素(TH)及垂體激素水平變化在中型顱腦損傷(MHI)、重型顱腦損傷(SHI)患者病情判斷及預(yù)后情況觀察中的臨床價(jià)值。方法:分析2010年1月~2015年12月在我院接受診治的50例HI患者的臨床資料。根據(jù)顱腦損傷(HI)病情嚴(yán)重程度將入選者分成MHI組(22例)和SHI組(28例)。根據(jù)預(yù)后情況將入選者分成存活組(S組,40例)和死亡組(D組,10例)。另外選取同期在我院接受健康體檢的45例健康者作為本次研究的對照組。比較MHI組、SHI組、對照組及S組和D組患者的TH(總?cè)饧紫僭彼酺T3、總甲狀腺素TT4、游離三碘甲腺原氨酸FT3和游離甲狀腺素FT4)、促甲狀腺激素(TSH)、血清泌乳素(PRL)及促卵泡生成素(FSH)等指標(biāo)的表達(dá)水平。結(jié)果:MHI組、SHI組與對照組的一般資料無顯著差異。MHI組患者的TT3、FT3明顯較SHI組患者高,PRL及FSH明顯較SHI組低,而TT4、FT4及TSH水平無顯著差異。MHI組、SHI組患者的TT3、FT3明顯較對照組低,PRL及FSH明顯較對照組高,而TT4、FT4及TSH水平無顯著差異。S組患者的TT3、FT3、PRL及FSH水平明顯優(yōu)于D組,而TT4、FT4及TSH水平無顯著差異。結(jié)論:HI患者的預(yù)后情況隨著其病情的加重而變差,且血清TT3、FT3、PRL及FSH可作為HI患者病情判斷及其預(yù)后觀察的重要指標(biāo)。
顱腦損傷;甲狀腺激素;垂體激素;預(yù)后
臨床上,下丘腦-垂體系統(tǒng)作用主要是對人體的代謝和內(nèi)分泌功能進(jìn)行有效調(diào)控,從而影響人體的多系統(tǒng)及多臟器功能,是完整的神經(jīng)內(nèi)分泌中樞系統(tǒng)之一。據(jù)報(bào)道,顱腦損傷(HI)會使下丘腦-垂體-甲狀腺軸系統(tǒng)功能在一定程度上出現(xiàn)異?,F(xiàn)象[1,2]。相關(guān)研究資料結(jié)果證實(shí),HI會擾亂患者的神經(jīng)內(nèi)分泌功能,致使患者的代謝功能發(fā)生異常,最終引發(fā)神經(jīng)源性多臟器受障[3]。目前有學(xué)者發(fā)現(xiàn),重型顱腦損傷(SHI)者的病情越嚴(yán)重,其體內(nèi)血清胃泌素及血糖水平則越高,且高濃度的胃泌素及血糖反之也會對患者的病情及其預(yù)后產(chǎn)生影響[4,5]。本研究旨在通過對中型顱腦損傷(MHI)、SHI者的甲狀腺激素(TH)及垂體激素濃度的變化與其預(yù)后情況的相關(guān)性的研究,以期為臨床判斷HI患者病情及其預(yù)后觀察提供一定的理論參考依據(jù)。
分析2010年1月~2015年12月在我院接受診治的50例HI患者的臨床資料。其中男40例,女10例,平均年齡(37.5±4.1)歲。根據(jù)格拉斯哥(GCS)計(jì)分情況對患者的病情給予準(zhǔn)確判斷:MHI者(9~12分)22例,SHI者(3~8分)28例。另外選取同期在我院接受健康體檢的45例健康者作為本次研究的對照組。根據(jù)HI病情嚴(yán)重程度將入選者分成MHI組(22例)和SHI組(28例)。MHI組、SHI組及對照組的一般資料無顯著差異(P>0.05),詳見表1。根據(jù)預(yù)后情況將入選者分成存活組(S組,40例)和死亡組(D組,10例)。
表1 MHI組和SHI組患者的一般資料比較
血樣的采集:采集受試者入院2h內(nèi) 8mL靜脈血,將血清分離并冷凍保存在-45℃的冰箱內(nèi)待測。采用由芬蘭Wallac Oy公司生產(chǎn)的儀器與試劑,以時(shí)間分辨熒光免疫法進(jìn)行檢測,重復(fù)2次檢測每份血清標(biāo)本并計(jì)算其平均值。
觀察指標(biāo):所有入選者的TH(總?cè)饧紫僭彼酺T3、總甲狀腺素TT4、游離三碘甲腺原氨酸FT3和游離甲狀腺素FT4)、促甲狀腺激素(TSH)、血清泌乳素(PRL)及促卵泡生成素(FSH)等指標(biāo)的表達(dá)水平。
本研究中的數(shù)據(jù)均采用SPSS19.0軟件進(jìn)行分析。數(shù)據(jù)計(jì)量以均數(shù)±標(biāo)準(zhǔn)差形式表示,比較采用t檢驗(yàn)和卡方(χ2)檢驗(yàn)。我們定義P<0.05為差異具有統(tǒng)計(jì)學(xué)意義。
表2結(jié)果提示MHI組患者的TT3、FT3明顯較SHI組患者高,PRL及FSH明顯較SHI組低(P<0.05),而TT4、FT4及TSH水平無顯著差異(P>0.05)。MHI組、SHI組患者的TT3、FT3明顯較對照組低,PRL及FSH明顯較對照組高(P<0.05),而TT4、FT4及TSH水平無顯著差異(P>0.05)。
表2 MHI組和SHI組各項(xiàng)指標(biāo)的水平比較
表3結(jié)果提示S組患者的TT3、FT3、PRL及FSH明顯較D組患者優(yōu)秀(P<0.01),而TT4、FT4及TSH水平無顯著差異(P>0.05)。
表3 S組和D組患者各項(xiàng)指標(biāo)的水平比較
目前,我國創(chuàng)傷性顱腦損傷(TBI)發(fā)病率呈逐年上升趨勢,致殘率、致死率均較高,其中中、重型顱腦損傷(MHI、SHI)患者居多。而甲狀腺與垂體激素出現(xiàn)異常變化是TBI的常見并發(fā)癥,發(fā)病率較高,其中垂體激素變化異常的主要發(fā)病機(jī)制是TBI后出現(xiàn)的垂體功能低下并發(fā)癥所致,其不僅會導(dǎo)致患者內(nèi)分泌紊亂,還會引發(fā)抑郁、認(rèn)知受損等神經(jīng)癥狀,此癥狀又極易與顱腦損傷的后遺癥混淆,故常常會導(dǎo)致誤診或漏診。
臨床上,急性顱腦損傷(HI)者體內(nèi)血清總?cè)饧紫僭彼幔═T3)及游離三碘甲腺原氨酸(FT3)水平顯著下降,而血清泌乳素(PRL)及促卵泡生成素(FSH)水平卻顯著增加,即FT3及FSH等水平的檢測對HI患者病情的判斷及其預(yù)后的評估、療效的評估等均具有極其重要的臨床意義[6]。本研究結(jié)果顯示,中型顱腦損傷(MHI)者的血清TT3、FT3濃度均顯著高于重型顱腦損傷(SHI)者,血清PRL、FSH水平則顯著低于SHI者,且MHI組、SHI組患者的TT3、FT3明顯較對照組低,PRL及FSH明顯較對照組高,提示HI患者激素水平明顯發(fā)生了變化,且HI病情程度越重,這種變化越顯著。
HI往往會引發(fā)下丘腦與垂體的直接(或間接)受損:直接暴力致使顱腔內(nèi)腦組織劇烈運(yùn)動,導(dǎo)致神經(jīng)垂體、垂體柄及腺垂體受損,嚴(yán)重時(shí)會引發(fā)垂體前葉及下丘腦梗死,對垂體功能造成不良影響;外傷導(dǎo)致顱內(nèi)壓陡然上升等引發(fā)下丘腦、垂體直接遭受壓力,從而導(dǎo)致垂體激素分泌受到很大地影響;外傷導(dǎo)致細(xì)胞本身與垂體柄受損,內(nèi)分泌功能失調(diào)或壞死[7],HI患者體內(nèi)血清FSH和PRL濃度大幅增加[8]?;颊呦虑鹉X受損,垂體前葉對促甲狀腺激素(TSH)的分泌功能會受到影響,TSH釋放激素的分泌量大幅下降,同時(shí)還會影響甲狀腺激素(TH)的分泌,導(dǎo)致三碘甲腺原氨酸(T3)、甲狀腺素(T4)水平降低[9]?;颊叩娘B內(nèi)壓由于HI的影響而顯著上升,腦部呈缺血缺氧狀,5’-脫碘酶(5’-D)和神經(jīng)細(xì)胞酶活性減弱,合成還原型輔酶II(NADPH)和谷胱甘肽(GSH)的能力降低且數(shù)量減少,T4轉(zhuǎn)化為T3的數(shù)目亦減少,同時(shí)組織自身所攝取的T4數(shù)量也不斷降低,最終導(dǎo)致活性T3的產(chǎn)生量大幅下降[10,11]。
目前學(xué)者們國內(nèi)外對HI患者體內(nèi)血清TT4水平的變化趨勢觀點(diǎn)不一[12]。有些學(xué)者發(fā)現(xiàn)HI患者的病情程度越嚴(yán)重,血清TT4水平會越低,但無統(tǒng)計(jì)學(xué)差異[13];還有學(xué)者認(rèn)為HI患者病情程度越高,血清TT4水平也明顯增加,且差異顯著[14]。本研究結(jié)果顯示,HI患者的病情加重時(shí),盡管血清TT4水平確實(shí)稍有增加,但兩者間無顯著差異,即SHI患者的血清TT4水平略高于MHI患者,提示患者體內(nèi)T4分泌量雖然有所下降,但T4轉(zhuǎn)化成T3的量也在減少,故患者體內(nèi)的血清T4水平未發(fā)現(xiàn)顯著改變。
總之,垂體激素及TH水平的變化可以作為HI患者病情判斷及預(yù)后情況觀察的重要指標(biāo),其均與HI患者病情關(guān)系密切,臨床上值得大力推廣。
[1] Miljic D, Miljic P, Doknic M, et al. Adipsic diabetes insipidus and venous thromboembolism (VTE): recommendations for addressing its hypercoagulability[J]. Hormones (Athens), 2014, 13(3): 420-3.
[2] 彭東海. 早期機(jī)械通氣在重型顱腦損傷中的臨床應(yīng)用價(jià)值[J]. 湖南師范大學(xué)學(xué)報(bào) (醫(yī)學(xué)版), 2008, 5(4): 40-43.
[3] Wiechecka J, Krzewska A, Droń I, et al. Panhypopituitarism after multisystem trauma[J]. Pediatr Endocrinol Diabetes Metab, 2013, 20(1):27-9.
[4] Ciancia S. Pituitary insufficiency after traumatic brain injury: consequences? Screening? [J]. Ann Fr Anesth Reanim, 2012, 31(6): e117-24.
[5] 鄭超, 喬陳財(cái), 唐紅軍, 等. 重型顱腦損傷患者血清 NSE 和 MMPs的動態(tài)變化及臨床意義[J]. 湖南師范大學(xué)學(xué)報(bào) (醫(yī)學(xué)版), 2016, 13(4): 107-109, 110.
[6] Widmayer MA, Browning JL, Gopinath SP, et al. Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury[J]. Neurol Res, 2010, 32(10): 1021-6.
[7] Nemes O, Kovacs N, Czeiter E, et al. Predictors of post-traumatic pituitary failure during long-term follow-up[J]. Hormones (Athens), 2015, 14(3): 383-91.
[8] Brod M, Pohlman B, H?jbjerre L, et al. Impact of adult growth hormone deficiency on daily functioning and well-being[J]. BMC Res Notes, 2014, 7: 813.
[9] KhKh S, Savin IA, Tenedieva VD, et al. [Analysis of thyroid homeostasis disorders in patients with severe traumatic brain injury][J]. Zh Vopr Neirokhir Im N N Burdenko, 2012, 76(4): 26-30; discussion 30-1.
[10] Tritos NA, Byrne TN, Wu CL, et al. A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening[J]. Nat Rev Endocrinol, 2011, 7(1): 54-9.
[11] Malekpour B, Mehrafshan A, Saki F, et al. Effect of posttraumatic serum thyroid hormone levels on severity and mortality of patients with severe traumatic brain injury[J]. Acta Med Iran, 2012, 50(2): 113-6.
[12] Karaca Z, Tanr?verdi F, ünlüh?zarc? K, et al. GH and Pituitary Hormone Alterations After Traumatic Brain Injury[J]. Prog Mol Biol Transl Sci, 2016, 138: 167-91.
[13] Melmed S. Idiopathic adult growth hormone deficiency[J]. J Clin Endocrinol Metab, 2013, 98(6): 2187-97.
[14] Villasana LE, Westbrook GL, Schnell E. Neurologic impairment following closed head injury predicts post-traumatic neurogenesis[J]. Exp Neurol, 2014, 261: 156-62.
The detective value of TH and pituitary hormones in patients with MHI and SHI
Zhang Ming, Wei Jian-bo
(The Central Hospital of Panzhihua City, Panzhihua 617067, China)
ObjectiveOur retrospective study was aimed to analyze the clinical value of the changes of the levels of TH and pituitary hormones in the illness evaluation and prognosis observation of MHI, SHI patients.MethodsClinical data of 50 patients with HI
treatment at our hospital from January, 2010 to December, 2015 was retrospectively analyzed. Patients included were divided into two groups according to the severity of HI patients, MHI group (22 cases) and SHI group (28 cases). Patients included were divided into two groups according to the prognosis of HI patients, survival group (S group, 40 cases) and death group (D group, 10 cases).45 healthy persons checked at the same time at our hospital were chosen as the control group. The levels of TH (TT3, FT3, TT4, FT4), TSH, PRL, FSH of patients on MHI group, SHI group and control group, S group and D group were respectively compared.ResultsThe general information in MHI group, SHI group and control group had no statistical difference. The levels of TT3, FT3 in MHI group were obviously higher than those in SHI group, and the levels of PRL and FSH in MHI group were obviously lower than those in SHI group, but the levels of TT4, FT4, TSH in MHI group and SHI group had no statistical difference. The levels of TT3, FT3 in MHI group, SHI group were obviously lower than those in control group, and the levels of PRL and FSH in MHI group, SHI group were obviously higher than those in control group, but the levels of TT4, FT4, TSH in MHI group, SHI group and control group had no statistical difference. The levels of TT3, FT3, PRL and FSH in S group were obviously better than those in D group, but the levels of TT4, FT4, TSH in S group and D group had no statistical difference.ConclusionThe prognosis of HI patients is worse as the degree of injury is more severe. The serum TT3, FT3, PRL and FSH could be regarded as the important indexes in determining the severity and prognosis of HI patients.
head injury (HI); thyroid hormone (TH); pituitary hormones; prognosis
R651.1
A
1673-016X(2017)05-0080-03
2017-04-10
張明,E-mail:714580176@qq.com